Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/31621
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMcMahon, James H-
dc.contributor.authorLau, Jillian S Y-
dc.contributor.authorColdham, Anna-
dc.contributor.authorRoney, Janine-
dc.contributor.authorHagenauer, Michelle-
dc.contributor.authorPrice, Sally-
dc.contributor.authorBryant, Mellissa-
dc.contributor.authorGarlick, Jill-
dc.contributor.authorPaterson, Anne-
dc.contributor.authorLee, Sue J-
dc.contributor.authorO'Bryan, Jess-
dc.contributor.authorHearps, Anna-
dc.contributor.authorTachedjian, Gilda-
dc.contributor.authorPinskier, Henry-
dc.contributor.authorPhillips, Cameron-
dc.contributor.authorGarrow, Stuart-
dc.contributor.authorPinskier, Nathan-
dc.contributor.authorMelvin, Robert-
dc.contributor.authorBlakeway, Luke-
dc.contributor.authorWisniewski, Jessica A-
dc.contributor.authorByers, Sally-
dc.contributor.authorBadoordeen, Gnei Z-
dc.contributor.authorPereira, Stephanie-
dc.contributor.authorPragastis, Katherine-
dc.contributor.authorTrubiano, Jason-
dc.contributor.authorChua, Kyra Y L-
dc.contributor.authorKainer, Marion-
dc.contributor.authorMolton, James S-
dc.contributor.authorGardiner, Bradley J-
dc.contributor.authorPierce, Anna B-
dc.contributor.authorCheng, Allen-
dc.contributor.authorRogers, Benjamin A-
dc.contributor.authorPeleg, Anton Y-
dc.date2022-
dc.date.accessioned2023-01-12T01:38:37Z-
dc.date.available2023-01-12T01:38:37Z-
dc.date.issued2022-12-
dc.identifier.citationEClinicalMedicine 2022; 54en_US
dc.identifier.issn2589-5370-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/31621-
dc.description.abstractWell tolerated antivirals administered early in the course of COVID-19 infection when the viremia is highest could prevent progression to severe disease. Favipiravir inhibits SARS-CoV-2 viral replication in vitro with evidence of clinical benefit in open label trials. Placebo controlled studies of people with early symptomatic COVID-19 with regular assessments of SARS-CoV-2 viral load can determine if it has an antiviral effect and improves clinical outcomes.en_US
dc.language.isoeng-
dc.subjectCOVID-19en_US
dc.subjectFavipiraviren_US
dc.subjectRandomised clinical trialen_US
dc.titleFavipiravir in early symptomatic COVID-19, a randomised placebo-controlled trial.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleEClinicalMedicineen_US
dc.identifier.affiliationDepartment of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Australia.en_US
dc.identifier.affiliationDepartment of Infectious Diseases, Monash Medical Centre, Melbourne, Australia.en_US
dc.identifier.affiliationLife Sciences Discipline, Burnet Institute, Melbourne, Australia.en_US
dc.identifier.affiliationOnsite Doctor and OSD.Care, Melbourne, Australia.en_US
dc.identifier.affiliationDepartment of Emergency Medicine, Alfred Hospital, Melbourne, Australia.en_US
dc.identifier.affiliationDepartment of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Australia.en_US
dc.identifier.affiliationInfectious Diseasesen_US
dc.identifier.affiliationDepartment of Infectious Diseases, Western Health, Melbourne, Australia.en_US
dc.identifier.doi10.1016/j.eclinm.2022.101703en_US
dc.type.contentTexten_US
dc.identifier.pubmedid36284645-
dc.description.volume54-
dc.description.startpage101703-
local.name.researcherChua, Kyra Y L-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptCentre for Antibiotic Allergy and Research-
crisitem.author.deptMicrobiology-
crisitem.author.deptInfectious Diseases-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

64
checked on Nov 22, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.